Travere Therapeutics Inc. (NASDAQ:TVTX) is one of the best mid-cap growth stocks to buy right now. On January 14, Bank of ...
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...
Investing.com -- HBM Healthcare Investments (SIX: HBMN) on Friday reported a quarterly profit of CHF 191 million in the third quarter, bringing nine-month earnings to CHF 286 million despite currency ...
The Food and Drug Administration has extended the review period for sparsentan in focal segmental glomerulosclerosis (FSGS).
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Quarterly profit of CHF 191 million brings the profit for the first nine months of the 2025/2026 financial year to a total of CHF 286 million ; Positive momentum in private and pu ...
CRMD and MIRM are advancing niche therapies with strong launches, rising sales and strategic acquisitions shaping their ...
Sionna Therapeutics, Inc., a clinical-stage biopharmaceutical company, researches and develops medicines for the treatment of cystic fibrosis (CF). It develops galicaftor (SION-2222), a transmembrane ...
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results